Searchable abstracts of presentations at key conferences on calcified tissues
Bone Abstracts (2016) 5 P130 | DOI: 10.1530/boneabs.5.P130

ECTS2016 Poster Presentations Cancer and bone: basic, translational and clinical (37 abstracts)

Uptake of different nitrogen containing bisphosphonate formulations by breast cancer cells

Hristo Zlatev 1 , Seppo Auriola 1 , Jukka Mönkkönen 1 & Jorma Määttä 1,


1School of Pharmacy, University of Eastern Finland, Kuopio, Finland; 2Department of Cel Biology and Anatomy, University of Turku, Turku, Finland.


Nitrogen-containing bisphosphonates (N-BPs) are used to treat osteolytic bone metastases. N-BPs have been previously shown to enter macrophages via macropinocytosis, but the mechanisms how they are taken up by breast cancer cells are so far incompletely known. In breast cancer primary tumours N-BPs have been shown, by other researchers, to be bound to micro-calcifications present in the tumour stroma. In our study we have characterized how different N-BP formulations, free, calcium-bound and liposome encapsulated are internalized to MCF-7 and T47D breast cancer cells.

All of the three different N-BP formulations were shown to utilize the various dynamin dependent endocytosis routes under which the T47D cells used more the clathrin-dependent route and MCF-7 cells a caveolin and clathrin independent route. In both of the cell lines the uptake of 14C-zoledronic acid was enhanced by calcium chelation of the drug (MCF7: free drug 50 c/s per mg protein vs [14C]-Zol-Ca2+2157 c/s per mg protein, P<0.001; T47D: 36.6 c/s per mg protein vs 3368.2 c/s per mg protein, P<0.001). Cytotoxicity was also enhanced by calcium chelation (IC50, MCF7 cells: free drug, 2.3×10−4 M vs calcium bound, 4.5×10−4 M, P<0.05; T47D cells: 8.97×10−4 M vs 7.2×10−5 M, P<0.001,respectively) and liposome encapsulation of the drug (MCF-7: 8×10−7 M, T47D: 6.9×10−6, P<0.001 for both of the cells lines when compared to the free drug). Liposome encapsulation favoured the use of the dynamin and caveolin dependent endocytosis route. Moreover, liposome encapsulation prolonged the drug effect in cells as monitored by the intracellular formation of isopentenyl pyrophosphate (IPP) and it AMP conjugate ApppI. At 72 h post treatment ApppI was still detected and the IPP concentration was highest in the cells treated with the liposomal drug. These findings suggest that breast cancer cells use different uptake mechanisms for N-BPs than macrophages, which is relevant when cell-specific targeting strategies for N-BPs are planned.

Volume 5

43rd Annual European Calcified Tissue Society Congress

Rome, Italy
14 May 2016 - 17 May 2016

European Calcified Tissue Society 

Browse other volumes

Article tools

My recent searches

No recent searches.